Endogenous Androgen Deficiency Enhances Diet-Induced Hypercholesterolemia and Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice

Gender Medicine

Volumn 9, Issue 5, 2012, Pages 319-328

  Hatch, Nicholas W ^a   Srodulski, Sarah J ^b   Chan, Huei Wei ^b   Zhang, Xuan ^a   Tannock, Lisa R ^a   King, Victoria L ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

androgen; atherosclerosis; cholesterol; estrogen

Indexed keywords

ANDROGEN; APOLIPOPROTEIN B; ESTROGEN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TESTOSTERONE; TRIACYLGLYCEROL;

ANDROGEN DEFICIENCY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CASTRATION; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE; SHAM PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANDROGENS; ANIMALS; ATHEROSCLEROSIS; DIET, FAT-RESTRICTED; FEMALE; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; LIPOPROTEINS, LDL; MALE; MICE; RECEPTORS, LDL; SEX FACTORS;

EID: 84867102025     PISSN: 15508579     EISSN: 18787398     Source Type: Journal    
DOI: 10.1016/j.genm.2012.08.003     Document Type: Article

References (38)

1. J.E. Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, E.E. van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res 53 2002 538 549
2. G.D. Kolovou, H.G. Bilianou Influence of aging and menopause on lipids and lipoproteins in women Angiology 59 Suppl 2008 54S 57S
3. D. Xing, S. Nozell, Y.-F. Chen Estrogen and mechanisms of vascular protection Arterioscler Thromb Vasc Biol 29 2009 289 295
4. J.E. Manson, J. Hsia, K.C. Johnson Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
5. J.E. Rossouw, G.L. Anderson, R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
6. S. Hulley, D. Grady, T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
7. S.M. Harman, E. Vittinghoff, E.A. Brinton Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes Am J Med 124 2011 199 205
8. P.F. Bray, J.C. Larson, A.Z. Lacroix Usefulness of baseline lipids and c-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events Am J Cardiol 101 2008 1599 1605
9. J. Makinen, M.J. Jarvisalo, P. Pollanen Increased carotid atherosclerosis in andropausal middle-aged men J Am Coll Cardiol 45 2005 1603 1608
10. J. Svartberg, D. von Muhlen, E. Mathiesen Low testosterone levels are associated with carotid atherosclerosis in men J Intern Med 259 2006 576 582
11. J.I. Makinen, A. Perheentupa, K. Irjala Endogenous testosterone and serum lipids in middle-aged men Atherosclerosis 197 2008 688 693
12. B.B. Yeap, Z. Hyde, O.P. Almeida Lower testosterone levels predict incident stroke and transient ischemic attack in older men J Clin Endocrinol Metab 94 2009 2353 2359
13. A.E. Hak, J.C. Witteman, F.H. de Jong Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the rotterdam study J Clin Endocrinol Metab 87 2002 3632 3639
14. F.C. Wu, A. von Eckardstein Androgens and coronary artery disease Endocr Rev 24 2003 183 217
15. R.R. Kalyani, A.S. Dobs Androgen deficiency, diabetes, and the metabolic syndrome in men Curr Opin Endocrinol Diabetes Obes 14 2007 226 234
16. J. Bourghardt, A.S. Wilhelmson, C. Alexanderson Androgen receptor-dependent and independent atheroprotection by testosterone in male mice Endocrinology 151 2010 5428 5437
17. Y. Qiu, T. Yanase, H. Hu Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development Endocrinology 151 2010 3307 3316
18. J.B. Hodgin, N. Maeda Minireview: estrogen and mouse models of atherosclerosis Endocrinology 143 2002 4495 4501
19. J.E. Nettleship, T.H. Jones, K.S. Channer, R.D. Jones Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the tfm mouse: an effect that is independent of the classic androgen receptor Circulation 116 2007 2427 2434
20. P. Alexandersen, J. Haarbo, I. Byrjalsen Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits Circ Res 84 1999 813 819
21. L. Nathan, W. Shi, H. Dinh Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase Proc Natl Acad Sci U S A 98 2001 3589 3593
22. T.K. Mukherjee, H. Dinh, G. Chaudhuri, L. Nathan Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis Proc Natl Acad Sci U S A 99 2002 4055 4060
23. T.A. Henriques, J. Huang, S.S. D'Souza Orchidectomy, but not ovariectomy, regulates angiotensin ii-induced vascular diseases in apolipoprotein e-deficient mice Endocrinology 145 2004 3866 3872
24. V.L. King, N.W. Hatch, H.W. Chan A murine model of obesity with accelerated atherosclerosis Obesity (Silver Spring) 18 2010 35 41
25. V.L. King, S.J. Szilvassy, A. Daugherty Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female ldl receptor-/- mice Arterioscler Thromb Vasc Biol 22 2002 456 461
26. N. Geary, L. Asarian, K.S. Korach Deficits in e2-dependent control of feeding, weight gain, and cholecystokinin satiation in er-α null mice Endocrinology 142 2001 4751 4757
27. J. Wu, X. Wang, H. Chiba Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice Metabolism 53 2004 942 948
28. N.H. Rogers, J.W. Perfield, K.J. Strissel Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity Endocrinology 150 2009 2161 2168
29. D.M. Daly, S.J. Park, W.C. Valinsky, M.J. Beyak Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse J Physiol 589 2011 2857 2870
30. M. Gil-Ortega, P. Stucchi, R. Guzmán-Ruiz Adaptative nitric oxide overproduction in perivascular adipose tissue during early diet-induced obesity Endocrinology 151 2010 3299 3306
31. M.E. Shaul, G. Bennett, K.J. Strissel Dynamic, m2-like remodeling phenotypes of cd11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice Diabetes 59 2010 1171 1181
32. T. Freudenberger, M. Oppermann, H.-K. Heim Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized apoe-deficient mice Basic Res Cardiol 105 2010 479 486
33. P.A. Bourassa, P.M. Milos, B.J. Gaynor Estrogen reduces atherosclerotic lesion development in apolipoprotein e-deficient mice Proc Natl Acad Sci U S A 93 1996 10022 10027
34. M. Tsuda, M. Iwai, J.-M. Li Inhibitory effects of at1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress Hypertension 45 2005 545 551
35. M.M. Marsh, V.R. Walker, L.K. Curtiss, C.L. Banka Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in ldl receptor-deficient mice J Lipid Res 40 1999 893 900
36. P.M. Cazita, J.A. Berti, C. Aoki Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice J Lipid Res 44 2003 33 40
37. M.R. Adams, D.L. Golden, A.A. Franke Dietary soy β-conglycinin (7s globulin) inhibits atherosclerosis in mice J Nutr 134 2004 511 516
38. R. Elhage, J.F. Arnal, M.T. Pieraggi 17 beta-estradiol prevents fatty streak formation in apolipoprotein e-deficient mice Arterioscler Thromb Vasc Biol 17 1997 2679 2684